Holen Sie sich die Stockscreener-App
2.00
1.96%
-0.04
Biote Corp Aktie (BTMD) Neueste Nachrichten
Biote names Komal Bajaj as chief medical officer By Investing.com - Investing.com Canada
CEO out after year leading hormone therapy company Biote - The Business Journals
Bob Peterson Named Interim CEO of Biote Corp., Effective May 28, 2026 - geneonline.com
Biote Names Its Chief Financial and Business Officer as Interim CEO - Dallas Innovates
Biote announces Christensen to step down as CEO, Peterson named interim CEO - TipRanks
Biote names Bob Peterson interim CEO as Christensen steps down - Investing.com UK
Biote Announces Management Changes - marketscreener.com
Biote Announces Chief Executive Officer Changes - marketscreener.com
Biote names CFO Bob Peterson as interim CEO, reaffirms FY26 outlook amid leadership shift - MSN
Biote Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com
Biote names Bob Peterson as interim CEO - marketscreener.com
Biote names Bob Peterson interim CEO as Christensen steps down By Investing.com - Investing.com Nigeria
Biote Board Retained Executive Search Firm to Assist With Identification, Evaluation of CFO Candidates >BTMD - Moomoo
Biote CEO steps down for family reasons as CFO Bob Peterson takes interim helm - Stock Titan
Number of shareholders of Biote Corp. – NASDAQ:BTMD - TradingView
Biote Corp. (BTMD) Extends Decline: Down 3.86% as Support Level Comes into FocusSpring Pattern - thelegaladvocate.com
BTMD Q1 2026 Earnings: Biote Corp. Beats EPS Estimates, Stock Declines SlightlyEarnings Call Highlights - Newser
biote shareholders elect directors and ratify Deloitte appointment - TipRanks
biote Corp. (NASDAQ: BTMD) investors back board nominees and Deloitte as 2026 auditor - Stock Titan
Biote maintains 2026 outlook above $190M revenue as it targets restoring Asteria supply by end of Q2 - MSN
BTMD SEC FilingsBiote 10-K, 10-Q, 8-K Forms - Stock Titan
biote Corp. (BTMD) director Andrew Heyer receives options and 35,259 deferred RSUs - Stock Titan
Dow Theory LettersBiote Corp.Class A common stock (Nasdaq:BTMD) Stock Quote - FinancialContent
biote (BTMD) director awarded 130,000 options and deferred RSUs - Stock Titan
biote Corp. (BTMD) grants options and RSUs to director - Stock Titan
biote (BTMD) director receives 130,000 options and 37,777 deferred RSUs - Stock Titan
biote Corp. (BTMD) director receives 195,000 stock options at $2.20 strike - Stock Titan
biote Corp. (BTMD) director Barrera receives 121,452 stock options at $2.20 - Stock Titan
Bandera Partners reports 2.07M shares in biote Corp. (BTMD) - Stock Titan
BTMD PE Ratio & Valuation, Is BTMD Overvalued - Intellectia AI
Earnings call transcript: Biote Corp reports Q1 2026 earnings miss amid recall impact By Investing.com - Investing.com South Africa
Earnings call transcript: Biote Corp reports Q1 2026 earnings miss amid recall impact - Investing.com
TradingKey - TradingKey
Pellet recall and lower revenue pressure biote Corp (NASDAQ: BTMD) in Q1 2026 - Stock Titan
BTMD surges 4.3% as Biote EPS crushes estimates by 23.7% in Q1 2026.Debt Refinancing - newser.com
Biote (BTMD) Q1 2026 Earnings Call Transcript - AOL.com
Biote Corp. Balances Recall Hit With Growth Plans - The Globe and Mail
Biote Corp.Class A common stock (NQ: BTMD - FinancialContent
Biote Corp. (BTMD) Q1 earnings and revenues lag estimates - MSN
biote Corp. (NASDAQ:BTMD) Q1 2026 Earnings Call Transcript - Insider Monkey
Biote Reports First Quarter Revenue Decline Due to Product Recall - HarianBasis.co
Biote : First Quarter 2026 Earnings Call Transcript - marketscreener.com
biote Corp. Q1 2026 Earnings Call Summary - Yahoo Finance
biote Q1 Earnings Call Highlights - MarketBeat
BTMD: Q1 revenue fell 8.3% year-over-year due to a recall, but full-year growth guidance remains unchanged - TradingView
BTMD: Recall-driven supply constraints led to lower Q1 revenue, but growth is expected to resume in H2 2026 - TradingView
biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates - Yahoo Finance
Earnings call transcript: Biote Corp reports Q1 2026 earnings miss - Investing.com
Earnings call transcript: Biote Corp reports Q1 2026 earnings miss By Investing.com - Investing.com Australia
Biote Corp. (BTMD) Releases Q1 2026 Earnings: Revenue Falls 8.3% While EPS Beats Estimates - Quiver Quantitative
Biote Q1 2026 Earnings Call: Complete Transcript - Benzinga
Biote Corp (NASDAQ:BTMD) Q1 2026: Revenue Miss Despite EPS Beat - ChartMill
Biote Reports First Quarter 2026 Financial Results - marketscreener.com
Biote (NASDAQ: BTMD) Q1 2026 results hit by recall but guidance held - Stock Titan
Biote Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Product recall hit Biote's quarter, but it still backs 2026 outlook - Stock Titan
3.29%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):